docetaxel,darolutamide
bayer
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel', 'arasens', 'darolutamide', 'bayer']
#bayer presented a subgroup analysis of the phase 3 arasens trial, demonstrating the overall survival of #darolutamide plus adt in combination with docetaxel across different populations with #prostatecancer #news #media #gu23 #ascogu23 #asco23 #ascogu2023
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma